Overview
- Active ingredient
- Loratadine
- Route
- Oral
- Label date
- 2024-11-25
Indications and usage
USE(S) Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Purpose
Purpose Antihistamine
Dosage and administration
DIRECTIONS Directions adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Warnings
Warnings
OTHER REQUIRED WARNINGS Other information For Bottle pack: Tamper-evident: do not use this product if the imprinted foil seal over the mouth of the bottle is cut, torn, broken or missing. For Blister pack: Tamper-evident: do not use if the individual blister unit is open or torn store between 20º to 25º C (68º to 77º F) FDA approved dissolution test specifications differ from USP
Do not use
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctor before use if
ASK A DOCTOR BEFORE USE IF Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
THIS PRODUCT When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if
AND ASK DOCTOR IF Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
Pregnancy or breast-feeding
PREGNANCY/BREASTFEEDING If pregnant or breast-feeding, ask a health professional before use.
Active ingredient (label)
(S) Active ingredient (in each tablet) Loratadine USP, 10 mg
Inactive ingredients
s Inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
Keep out of reach of children
OF CHILDREN Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).